AKT1 and overactive bladder: Our data also revealed that treatment with ketamine significantly increased phosphorylation of Akt, induced mitochondrial and organelle swelling and degeneration, inhibited angiogenesis, damaged endothelial cells, induced mast cell and eosinophil-mediated inflammation, enhanced interstitial fibrosis, and led to bladder overactivity [62].